11 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

REUSABLE TENS PARAVERTEBRAL PAD #641 BACK ELECTROD

FDA 510(k)
FDA Class 2 ·Neurology

Printed Lower ROC Pack for Herbst LL4 10mm,

FDA UDI
SPECIALTY APPLIANCES, LLC·D8199015750·

Map-iT

FDA UDI
ACCESS POINT TECHNOLOGIES, INC.·00818083014650·Fixed, 10 electrode, S, 2-10-2mm electrode spacing

N/A

FDA UDI
MEDTRONIC SOFAMOR DANEK, INC.·00673978079684·DISTRACTOR 901-575 C-STYLE 22/14MM

CMDR 2C (Multiple Models)

FDA 510(k)
FDA Class 2 ·Radiology

APEX MODULAR HEAD, SIZE 28 ,32, 26 AND 40 MM+10.5 OFFSET, MODELS 302810, 303210,303610,304010

FDA 510(k)
FDA Class 2 ·Orthopedic

IVORY CLAMP

FDA Adverse Event
Malfunction ·HERAEUS KULZER LLC·Product code EEF·June 30, 2014

VASO VIEW HEMOPRO

FDA Adverse Event
Malfunction ·MAQUET CARDIOVASCULAR, LLC·Product code GEI·January 4, 2013

ANIMAS INSULIN INFUSION PUMP

FDA Adverse Event
Malfunction ·ANIMAS CORP.·Product code LZG·November 10, 2010

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

The UniCel DxI 600 and 800 Access Immunoassay Systems, that are connected to an automation line. UniCel DxI 600 Catalog Numbers: A30260, A71460, A71461, A92060. Unicel DxI 800 Catalog Numbers: 973100, A71456, A71457, A84545, A25288, A25285.

FDA Enforcement
Class II ·Ongoing·Beckman Coulter Inc.·April 10, 2019